Immuno-Biological Laboratories Co., Ltd.TSE 4570

株式会社免疫生物研究所 · Pharmaceutical · FY ends Mar

Share price at FY-end
¥1,342
FY ending Mar 2026
Market cap at FY-end
¥12.5B
Dividend per share
¥6.0
Avg. director pay
¥14.2M
Internal directors

Top 10 shareholders

#ShareholderSharesStakeValueDividends
1 Tsutomu Kiyofuji 1,123,700 12.07% ¥1.5B ¥6.7M
2 楽天証券株式会社共有口 253,300 2.72% ¥340M ¥1.5M
3 株式会社トランスジェニックグループ 160,000 1.72% ¥215M ¥960,000
4 中沢 祥子 101,600 1.09% ¥136M ¥609,600
5 株式会社東和銀行 100,000 1.07% ¥134M ¥600,000
6 土井 勝之 95,000 1.02% ¥128M ¥570,000
7 林 剛徳 82,500 0.89% ¥111M ¥495,000
8 林 ラヒム 70,000 0.75% ¥94.0M ¥420,000
9 野村證券株式会社
Asset-management company of 野村 浩子
63,100 0.68% ¥84.7M ¥378,600
10 NOMURA INTERNATIONAL PLC A/C JAPAN FLOW 62,500 0.67% ¥83.9M ¥375,000

Officers' holdings and pay

NameTitleSharesValuePay
Tsutomu Kiyofuji President & Representative Director 1,123,700 ¥1.5B —
中川 正人 Managing Director 11,100 ¥14.9M —
小野寺 昭子 Director 50,000 ¥67.1M —
福永 健司 Director — — —
岡住 貞宏 Director — — —
小嶋 一慶 Director (Audit & Supervisory Committee Member) — — —
兒島 宏和 Director (Audit & Supervisory Committee Member) — — —

Pay is shown only for officers whose pay of ¥100 million or more is disclosed individually.

Per-share data by fiscal year

Fiscal yearPriceEPSP/EDividendShares issued
FY ending Mar 2026 ¥1,342 ¥35.33 38.0x ¥6.0 9,314,590
FY ending Mar 2025 ¥481 ¥26.74 18.0x — 9,314,590
FY ending Mar 2024 ¥529 ¥20.05 26.4x — 9,314,590
Source: annual securities reports on EDINET. Values are estimates. Methodology